Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,874.00    -146.00 (-3.63%)
Bid:
3,898.00
Ask:
3,900.00
Spread: 2.00 (0.051%)
Market Cap: £14.63b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
20th Mar 20136:07 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSAcquisition
1st Mar 201311:33 amRNSTotal Voting Rights
21st Feb 201312:47 pmRNSDirector/PDMR Shareholding
14th Feb 20132:00 pmRNSHalma - New Reporting Sectors
14th Feb 20137:00 amRNSInterim Management Statement
1st Feb 20132:32 pmRNSTotal Voting Rights
24th Jan 20132:15 pmRNSTreasury Stock
23rd Jan 20139:00 amRNSAcquisition
18th Jan 201312:16 pmRNSBlocklisting Interim Review
2nd Jan 20133:51 pmRNSTotal Voting Rights
21st Dec 20123:36 pmRNSDirector/PDMR Shareholding
19th Dec 20127:00 amRNSAcquisition
14th Dec 20123:32 pmRNSTreasury Stock
3rd Dec 201210:48 amRNSTotal Voting Rights
26th Nov 201211:10 amRNSHolding(s) in Company
23rd Nov 20125:11 pmRNSTreasury Stock
23rd Nov 20122:21 pmRNSDirector/PDMR Shareholding
20th Nov 201212:25 pmRNSDoc re. Half Year Report 2012/13
20th Nov 20127:00 amRNSHalf Yearly Report
16th Nov 20124:27 pmRNSTreasury Stock
12th Nov 20122:52 pmRNSNotice of Results
1st Nov 20124:33 pmRNSTotal Voting Rights
30th Oct 20129:36 amRNSTreasury Stock
2nd Oct 20125:03 pmRNSDirector/PDMR Shareholding
1st Oct 20123:08 pmRNSTotal Voting Rights
27th Sep 20125:08 pmRNSTreasury Stock
21st Sep 20124:07 pmRNSTreasury Stock
21st Sep 20123:49 pmRNSHolding(s) in Company
20th Sep 20124:24 pmRNSTreasury Stock
6th Sep 20123:37 pmRNSTreasury Stock
3rd Sep 201211:35 amRNSTotal Voting Rights
31st Aug 20123:10 pmRNSDirector/PDMR Shareholding
23rd Aug 20127:00 amRNSDisposal
14th Aug 20129:00 amRNSAnnual Information Update
8th Aug 20129:34 amRNSShare Transactions and Purchase of Own Shares
2nd Aug 201212:17 pmRNSBlocklisting Interim Review
1st Aug 20123:14 pmRNSTotal Voting Rights
25th Jul 20122:57 pmRNSDirector/PDMR Shareholding
25th Jul 20122:51 pmRNSResult of AGM
24th Jul 20127:00 amRNSAGM Statement
3rd Jul 20129:39 amRNSTotal Voting Rights
25th Jun 201211:26 amRNSAnnual Financial Report
14th Jun 20127:00 amRNSFinal Results
8th Jun 20128:41 amRNSNotice of Results
1st Jun 201212:04 pmRNSTotal Voting Rights
31st May 20121:50 pmRNSDirector Declaration
31st May 20129:27 amRNSAcquisition
28th May 20123:22 pmRNSDirector Declaration
14th May 201210:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.